# Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Patients With Persistent AF

> **NCT02492256** · PHASE2 · UNKNOWN · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 60 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Pulmonary vein isolation
- **DEVICE:** GP ablation guided by SUMO technology
- **DEVICE:** ILR implantation

## Key facts

- **NCT ID:** NCT02492256
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2016-05
- **Final completion:** 2016-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492256, "Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Patients With Persistent AF". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02492256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*